Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT® anti-HBc assay: Analysis of borderline reactive sera

Journal of Virological Methods

Volumn 154, Issue 1-2, 2008, Pages 206-209

  Ollier, Laurence ^a   Laffont, Catherine ^a   Kechkekian, Aurore ^a   Doglio, Alain ^a   Giordanengo, Valérie ^a,b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

Author keywords

Anti HBc antibodies; Diagnostic virology; HBV; Hepatitis B infection; Immunoassays

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEROLOGY;

FRANCE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; PREDICTIVE VALUE OF TESTS;

HEPATITIS B VIRUS;

EID: 56249087900     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.09.006     Document Type: Article

References (20)

1. Arraes L.C., Ximenes R., Andrieu J.M., Lu W., Barreto S., Pereira L.M., and Castelo A. The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers. Rev. Inst. Med. Trop. Sao Paulo 45 3 (2003) 137-140
2. Barazani Y., Hiatt J.R., Tong M.J., and Busuttil R.W. Chronic viral hepatitis and hepatocellular carcinoma. World J. Surg. 31 6 (2007) 1245-1250
3. Barcena R., Moraleda G., Moreno J., Martin M.D., de Vicente E., Nuno J., Mateos M.L., and del Campo S. Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers. World J. Gastroenterol. 12 13 (2006) 2070-2074
4. Behzad-Behbahani A., Mafi-Nejad A., Tabei S.Z., Lankarani K.B., Torab A., and Moaddeb A. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J. Med. Res. 123 1 (2006) 37-42
5. Calabrese L.H., Zein N.N., and Vassilopoulos D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann. Rheum. Dis. 65 8 (2006) 983-989
6. Chen D., Kaplan L., and Liu Q. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers. Clin. Chim. Acta 355 1-2 (2005) 41-45
7. Chevaliez S., and Pawlotsky J.M. Screening and diagnosis of hepatitis B and C. Rev. Prat. 55 6 (2005) 615-623 (in French)
8. Coiffier B. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis. Cancer Invest. 24 5 (2006) 548-552
9. Grob P., Jilg W., Bornhak H., Gerken G., Gerlich W., Gunther S., Hess G., Hudig H., Kitchen A., Margolis H., Michel G., Trepo C., Will H., Zanetti A., and Mushahwar I. Serological pattern "anti-HBc alone": report on a workshop. J. Med. Virol. 62 4 (2000) 450-455
10. Kafatos G., Anastassopoulou C., Nardone A., Andrews N., Barbara C., Boot H.J., Butur D., Davidkin I., Gelb D., Griskevicius A., Hesketh L., Icardi G., Jones L., Kra-Oz Z., Miller E., Mossong J., Nemecek V., de Ory F., Sobotova Z., Thierfelder W., Van Damme P., and Hatzakis A. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus. J. Viral. Hepat. 14 4 (2007) 260-268
11. Lalazar G., Rund D., and Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br. J. Haematol. 136 (2007) 699-712 (Erratum in: Br J Haematol. 2007, 137 (1), 81)
12. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 45 2 (2007) 507-539
13. Murakami Y., Minami M., Daimon Y., and Okanoue T. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J. Med. Virol. 72 2 (2004) 203-214
14. Pawlotsky J.M. Virology of hepatitis B and C viruses and antiviral targets. J. Hepatol. 44 1 Suppl. (2006) S10-S13
15. Taylor P., Pickard G., Gammie A., and Atkins M. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. J. Clin. Virol. 30 Suppl. 1 (2004) S11-S15
16. Trepo C., Zoulim F., Alonso C., Petit M.A., Pichoud C., and Vitvitski L. Diagnostic markers of viral hepatitis B and C. Gut 34 2 Suppl. (1993) S20-S25
17. Weber B., Michl U., Muhlbacher A., Paggi G., and Bossi V. Evaluation of the new automated enzymun-test anti-HBc plus for the detection of hepatitis B virus core antibody. Intervirology 41 1 (1998) 17-23
18. Weber B., Melchior W., Gehrke R., Doerr H.W., Berger A., and Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J. Med. Virol. 64 3 (2001) 312-319
19. Wiesner D., Krishnan K., Templin L., Storck-Schattner D., Dellamorte M., Williams G., Herrmann R., Bartko K., and Rios W. Reformulation of ARCHITECT Anti-HBc Assay* improves specificity performance. Posted communication in 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine. Amsterdam, The Netherlands, June 3-7 (2007)
20. Zarski J.P. Epidemiology of chronic hepatitis B. Presse Med. 35 2 Pt 2 (2006) 304-307